Safe resumption of electroconvulsive therapy after Non-ST segment elevation myocardial infarction

Journal of ECT

Volumn 27, Issue 1, 2011, Pages e39-e41

  Aloysi, Amy S ^a   Maloutas, Eleni ^a   Gomes, Anthony ^a   Kellner, Charles H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

ECT; Myocardial infarction; NSTEMI

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; ARIPIPRAZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUOXETINE; GLYCOPYRRONIUM BROMIDE; HALOPERIDOL; INSULIN GLARGINE; LABETALOL; LAMOTRIGINE; LITHIUM; METFORMIN; METHOHEXITAL; MIRTAZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTRALINE; SUXAMETHONIUM; ZIPRASIDONE;

AGED; AGITATION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DEPRESSIVE PSYCHOSIS; DISEASE COURSE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; ELECTROCONVULSIVE THERAPY; FEMALE; HEART RATE; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; RISK REDUCTION; SIDE EFFECT; TACHYCARDIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

AGED; BIPOLAR DISORDER; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; MYOCARDIAL INFARCTION; SAFETY;

EID: 79952192396     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181f41da5     Document Type: Article

References (11)

1. Nuttall GA, Bowersox MR, Douglass SB, et al. Morbidity and mortality in the use of electroconvulsive therapy. J ECT. 2004;20(4): 237-241.
2. Gardner MW, Kellner CH, Hood DE, et al. Safe administration of ECT in a patient with a cardiac aneurysm and multiple cardiac risk factors. Convuls Ther. 1997;13(3): 200-203.
3. Lynch AM, Pandurangi AK, Levenson JL. Electroconvulsive therapy in a candidate for heart transplant with an implantable cardiovertor defibrillator and cardiac contractility modulator. Psychosomatics. 2008;49(4): 341-344.
4. Kellner CH, Monroe RR, Burns C, et al. Electroconvulsive therapy in a patient with a heart transplant. N Engl J Med. 1991;325(9): 663.
5. O’Reardon JP, Lott JP, Akhtar UW, et al. Acute coronary syndrome (Takotsubo cardiomyopathy) following electroconvulsive therapy in the absence of significant coronary artery disease: case report and review of the literature. J ECT. 2008;24(4): 277-280.
6. Electroconvulsive therapy. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement. 1985;5(11): 8.
7. Magid M, Lapid MI, Sampson SM, et al. Use of electroconvulsive therapy in a patient 10 days after myocardial infarction. J ECT. 2005;21(3): 182-185.
8. Messina AG, Paranicas M, Katz B, et al. Effect of electroconvulsive therapy on the electrocardiogram and echocardiogram. Anesth Analg. 1992;75(4): 511-514.
9. Weiner MB, Partridge BL, Hauger R, et al. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy. I. Effectiveness of pretreatment regimens on hemodynamics. Anesth Analg. 1991;73(5): 556-562.
10. McCall WV. Asystole in electroconvulsive therapy: Report of four cases. J Clin Psychiatry. 1996;57(5): 199-203.
11. Sutor B, Mueller PS, Rasmussen KG. Bradycardia and hypotension in a patient with severe aortic stenosis receiving electroconvulsive therapy dose titration for treatment of depression. J ECT. 2008;24(4): 281-282.